For the employees of the German medical company BioNTech, it is an “emotional day.”
As we are in the heart of the EU, we are delighted to be one step closer to the possible delivery of the first vaccine in Europe to this devastating pandemic, “said President Ugur Sahin to the approval by the European Medicines Agency EMA.
“We are ready to start delivering the first vaccine doses across the EU as soon as we get the green light,” said Sahin.
On Monday evening, the European Commission will take a final decision on the authorization of the vaccine, which has been given the name Comirnaty and also referred to as BNT162b2.
Pfizer, too, is “pleased with the enormous confidence the committee has in our data”, CEO Albert Bourla refers to the EMA’s drug evaluation committee, which has conducted the substantive evaluation of the vaccine.
“If the European Commission gives its approval, we are there ready to begin delivery of this vaccine to government-designated locations across the EU, where the incidence of the disease continues to increase and where several countries are in lockdowns. “